Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients

NCT01641783 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: nanoparticle Albumin-Bound paclitaxel

Sponsor

Yanqiao Zhang